Life Science Partner recruits former Vice President, Research and Development, Remote Patient Monitoring at Boston Scientific
Life Science Partner announces the recruitment of John Lalonde, an innovative senior medical device executive, to become Vice President, Product Development, Technology and Stimulation Research for Medtronic Neuromodulation. Neuromodulation is Medtronic’s second oldest and fourth largest business unit, with products that include neurostimulation systems and implantable drug delivery systems for chronic pain, common movement disorders, and urology and gastrointestinal disorders.
During his tenure at Boston Scientific, Lalonde was responsible for the development of LATITUDE, a cloud-based FDA class III home monitoring system for cardiac patients with wireless medical device implants treating arrhythmias and heart failure. Previously, LaLonde served as General Manager, Global Engineering, Clinical Systems for GE Healthcare, where he was a global engineering leader of GE’s critical care business unit for neonatal, ICU, and OR patient monitoring and wireless cardiac monitoring systems.
In his new role at Medtronic Diabetes, Lalonde will be serve as the functional leader of Medtronic’s Neuromodulation Business Senior Leadership Team, to drive excellence in product development, technology and stimulation research.
“LaLonde is a talented engineering leader and innovator”, noted Tom Callaway, MD, founder and president of Life Science Partner. “He has a depth of business knowledge and global commercialization experience that extends from value engineering to global customer reach. He will bring leadership and quality execution to Medtronic’s Neuromodulation portfolio of stimulation and drug delivery solutions.”
LaLonde earned a Bachelor of Science Degree in Physics from the University of Minnesota and his Masters in Biomedical Engineering from the University of Wisconsin.